Published in

Centers for Disease Control and Prevention, Emerging Infectious Diseases, 1(13), p. 180-182, 2007

DOI: 10.3201/eid1301.060819

Centers for Disease Control and Prevention, Emerging Infectious Diseases, 1(13), p. 178-179

DOI: 10.3201/eid1301.060945

Centers for Disease Control and Prevention, Emerging Infectious Diseases, 1(13), p. 179-180

DOI: 10.3201/eid1301.060611

Links

Tools

Export citation

Search in Google Scholar

Human Bocavirus in Febrile Children, the Netherlands

This paper is made freely available by the publisher.
This paper is made freely available by the publisher.

Full text: Download

Green circle
Preprint: archiving allowed
Green circle
Postprint: archiving allowed
Green circle
Published version: archiving allowed
Data provided by SHERPA/RoMEO

Abstract

sis of discharge data to compare find- ings from the United States with data from Germany. We therefore deter- mined the absolute number of inpa- tient discharges from all hospitals in Germany with the number of dis- charge diagnoses of CDAD reported in the national Statistische Bundesamt for the years 2000-2004. We then cal- culated the incidence of CDAD as a discharge diagnosis for each year and stratified our results by age groups (Figure). Our results confirm the observa- tions from the United States. The effect of C. difficile on illness of patients in hospitals in Germany has escalated dramatically. This is true especially for patients >60 years of age. This trend indicates the need for increased awareness of this pathogen and a concerted effort to control CDAD by reducing unnecessary antimicrobial drug use and imple- menting currently recommended infection control measures. It also highlights the need to develop more rapid and accurate diagnostic tools and more effective prevention and treatment strategies.